1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (401) 457-3332
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Actinic keratoses†‡
Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Article first published online: 20 APR 2009
DOI: 10.1002/cncr.24284
Published 2009 American Cancer Society
Additional Information
How to Cite
Criscione, V. D., Weinstock, M. A., Naylor, M. F., Luque, C., Eide, M. J., Bingham, S. F. and for the Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group (2009), Actinic keratoses. Cancer, 115: 2523–2530. doi: 10.1002/cncr.24284
- †
Key personnel of the Department of Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial include the following: Study Chairman's Office: Martin A. Weinstock (Chair) and Kimberly Marcolivio (Providence, RI). Executive Committee: Martin Weinstock (Providence, RI), Stephen Bingham (Perry Point, Md), John DiGiovanna (Providence, RI), Russell Hall (Durham, NC), Mark Naylor (Oklahoma City, Okla), J. Richard Taylor (Miami, Fla), Julia Vertrees (Albuquerque, NM), and Clifton White (Portland, Ore). Clinical Centers: Durham, NC (Russell Hall and Deborah Hannah); Chicago, Ill (Hines) (David Eilers, Tehming Liang, Nadia Sakla, and Ann Kreuger); Long Beach, Calif (Gary Cole, Edward Jeffes, and Terri Labrador); Miami, Fla (J. Richard Taylor, Robert Kirsner, Jonette E. Kerri, Anna G. Falabela, and Margarita Givens); Oklahoma City, Okla (Mark Naylor, Mary Beth Benson, and Lisa Perry); and Phoenix, Ariz (James Kalivas, Catherine Yanni, Selma Targovnik, Janet Austin, and Susan Collier). Cooperative Studies Program Coordinating Center (Perry Point, Md): Joseph F. Collins, Stephen Bingham, Beverly Calvert, Philip Connor, Colleen Crigler, Dawn Davis, Pat Grubb, Judy Kelly, Gail Kirk, Karen Lawson, Linda Linzy, Lorrine Palmer, and Maxine Rhoads. Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (Albuquerque, NM): Mike Sather, Erica Copeland, Carol Fye, William Gagne, Patricia Grimes de Naranjo, Chad Messick, and Julia Vertrees. Dermatopathologists: Michael Piepkorn (Bellevue, Wash) and Clifton White (Portland, Ore). Data and Safety Monitoring Board: Robert Lew (Boston, Mass), Irwin Braverman (New Haven, Conn), Bernard Cole (Lebanon, NH), Richard Kalish (Stony Brook, NY), David McLean (Vancouver, BC, Canada), and Bruce Thiers (Charleston, SC).
- ‡
This article is US Government work and, as such, is in the public domain in the United States of America.
Publication History
- Issue published online: 20 MAY 2009
- Article first published online: 20 APR 2009
- Manuscript Accepted: 20 NOV 2008
- Manuscript Revised: 14 NOV 2008
- Manuscript Received: 25 SEP 2008
Funded by
- Cooperative Studies Program (CSP) Grant 402 from the US Department of Veterans Affairs Office of Research and Development
- Summer Research Assistantship Grant from the Alpert Medical School of Brown University
- Brown University Department of Dermatology
- National Institutes of Health. Grant Numbers: R01CA106592, R01CA106807, R25CA087972, R01AR49342
References
- 1,,. Actinic keratosis. Int J Dermatol. 2007; 46: 895-904.Direct Link:
- 2,,,,,. Frequency and cost of actinic keratosis treatment. Dermatol Surg. 2006; 32: 1045-1049.Direct Link:
- 3,,, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006; 55: 490-500.
- 4,,,. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006; 16: 335-339.
- 5,,. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988; 1: 795-797.
- 6,,,,. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention: VATTC Trial. J Natl Cancer Inst. 2008; 100: 1223-1232.
- 7,,, et al;Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group. Topical tretinoin and all-cause mortality. Arch Dermatol. 2009; 145: 18-24.
- 8,,,. Reliability of the histopathologic diagnosis of keratinocyte carcinomas. J Am Acad Dermatol. 2007; 57: 279-284.
- 9,,,. Solar keratosis: epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol. 2007; 48: 67-74; quiz 75-76.Direct Link:
- 10,. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol. 1997; 133: 1263-1270.
- 11,,, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007; 156( suppl 3): 8-12.Direct Link:
- 12,. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 2006; 155: 9-22.Direct Link:
- 13,,,,. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986; 115: 649-655.Direct Link:
- 14,,,,. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer. 1996; 74: 1302-1307.
- 15,. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg. 2007; 33: 1099-1101.Direct Link:
- 16,. Verruca selinis and keratoma senile. Archiv für Dermatologie and Syphilis. 1932; 166: 286-296.
- 17,,, et al. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA Topical Tretinoin Chemoprevention (VATTC) trial. Arch Dermatol. 2001; 137: 1055-1058.
- 18,. Epidemiology of solar keratoses. Br J Dermatol. 1994; 131: 455-464.Direct Link:
- 19,,. The prevalence and accuracy of non-melanotic skin cancer in Victoria. Australas J Dermatol. 1983; 24: 79-82.Direct Link:
- 20,,,. Clinical recognition of actinic keratoses in a high-risk population: how good are we? Arch Dermatol. 2005; 141: 507-509.
- 21,,,,,. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995; 131: 170-175.
- 22,,,. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 2002; 6: 207-209.
- 23,,,. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol. 1998; 37: 677-681.Direct Link:
- 24,,,,. Basosquamous carcinoma. Dermatol Surg. 2003; 29: 830-832.Direct Link:
- 25. Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma? J Clin Pathol. 1985; 38: 1273-1277.
- 26
- 27,,, et al. Skin cancer in Geraldton, Western Australia: a survey of incidence and prevalence. Med J Aust. 1990; 152: 399-407.
- 28,,. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol. 2000; 115: 273-277.
- 29,,,. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol. 1991; 127: 1029-1031.
- 30The Lewin Group. The Burden of Skin Diseases 2004. Cleveland, OH: Society for Investigative Dermatology; Washington, DC: American Academy of Dermatology Association; 2006.